|Hallmarks of glycosylation in cancer|
J Munkley, DJ Elliott
Oncotarget 7 (23), 35478, 2016
|EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia|
V Boczonadi, JS Müller, A Pyle, J Munkley, T Dor, J Quartararo, I Ferrero, ...
Nature communications 5 (1), 1-13, 2014
|The role of sialyl-Tn in cancer|
International journal of molecular sciences 17 (3), 275, 2016
|The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer|
J Munkley, S Oltean, D Vodák, BT Wilson, KE Livermore, Y Zhou, E Star, ...
Oncotarget 6 (33), 34358, 2015
|The role of glycans in the development and progression of prostate cancer|
J Munkley, IG Mills, DJ Elliott
Nature Reviews Urology 13 (6), 324, 2016
|Glycosylation is an androgen-regulated process essential for prostate cancer cell viability|
J Munkley, D Vodak, KE Livermore, K James, BT Wilson, B Knight, ...
EBioMedicine 8, 103-116, 2016
|RNA splicing and splicing regulator changes in prostate cancer pathology|
J Munkley, K Livermore, P Rajan, DJ Elliott
Human genetics 136 (9), 1143-1154, 2017
|Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells|
J Munkley, NP Lafferty, G Kalna, CN Robson, HY Leung, P Rajan, ...
BMC cancer 15 (1), 1-11, 2015
|A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation|
J Munkley, P Rajan, NP Laferty, C Dalgliesh, RM Jackson, CN Robson, ...
Oncotarget 5 (1), 131, 2014
|The glycosylation landscape of pancreatic cancer|
Oncology letters 17 (3), 2569-2575, 2019
|The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells|
J Munkley, KE Livermore, UL McClurg, G Kalna, B Knight, P McCullagh, ...
Oncoscience 2 (9), 755, 2015
|Glycans as biomarkers in prostate cancer|
E Scott, J Munkley
International Journal of Molecular Sciences 20 (6), 1389, 2019
|Cyclin E is recruited to the nuclear matrix during differentiation, but is not recruited in cancer cells|
J Munkley, NA Copeland, V Moignard, JRP Knight, E Greaves, ...
Nucleic acids research 39 (7), 2671-2677, 2011
|Glycosylation is a global target for androgen control in prostate cancer cells|
Endocrine-Related Cancer 24 (3), R49-R64, 2017
|JNK/SAPK signaling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells|
I Neganova, E Shmeleva, J Munkley, V Chichagova, G Anyfantis, ...
Stem Cells 34 (5), 1198-1212, 2016
|Androgen receptor and prostate cancer|
KE Livermore, J Munkley, DJ Elliott
AIMS Molecular Science 3 (2), 280, 2016
|ST6GAL1: A key player in cancer|
R Garnham, E Scott, KE Livermore, J Munkley
Oncology letters 18 (2), 983-989, 2019
|The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration|
J Munkley, UL McClurg, KE Livermore, I Ehrmann, B Knight, P Mccullagh, ...
Scientific reports 7 (1), 1-11, 2017
|Metronidazole toxicity in Cockayne syndrome: a case series|
BT Wilson, A Strong, S O’Kelly, J Munkley, Z Stark
Pediatrics 136 (3), e706-e708, 2015
|Targeting aberrant sialylation to treat cancer|
J Munkley, E Scott
Medicines 6 (4), 102, 2019